Press Releases

Date Title
Jan 13, 2025 Chimerix to Speak Today at The White House Cancer Moonshot Forum
Chief Scientific Officer, Joshua E. Allen, Ph.D. to Highlight Cancer Moonshot’s Impact on Brain Cancer and Rare Pediatric Disease Drug Development DURHAM, N.C. , Jan. 13, 2025 (GLOBE NEWSWIRE) -- Chimerix (NASDAQ: CMRX), a biopharmaceutical company whose mission it is to develop medicines that
  • Print
  • Email Alerts
  • RSS Feeds
  • Search
  • Share
scroll back to top of page